Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 1
Auto-generated profile, based on publicly available information
Ying Xiao
Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 1
Circulating proteomic signatures of age are closely associated with aging and age-related diseases; however, the utility of changes in secreted proteins in identifying therapeutic targets for diseases remains unclear. Serum proteomic profiling of an age-stratified healthy population and further community-based cohort together with heart failure patients study demonstrated that circulating C-C motif chemokine ligand 17 (CCL17) level increased with age and correlated with cardiac dysfunction. Subsequent animal experiments further revealed that Ccll7-KO significantly repressed aging and angiotensin II (Ang II)–induced cardiac hypertrophy and fibrosis, accompanied by the plasticity and differentiation of T cell subsets. Furthermore, the therapeutic administration of an anti-CCL17 neutralizing antibody inhibited Ang II–induced pathological cardiac remodeling. Our findings reveal that chemokine CCL17 is identifiable as a novel therapeutic target in age-related and Ang II–induced pathological cardiac hypertrophy and heart failure.
23 September 2003 in Acta Crystallographica Section C Crystal Structure Communications
On the basis of relevant enterprise development theories, this paper conducts regression analysis on the financial data of hundreds of leading listed companies on GEM in China to study their development ability and existing problems. Through empirical analysis, it is found that the internal ownership structure of a company can well guide its development. The research conclusion shows that the shareholders holding the most shares in a company inhibit its development, while the shares held by other shareholders and legal persons are beneficial to its development. The other shares, which account for a relatively low ratio, have no great influence on the development of a company and present an irrelevant relationship.